CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Feb. 28, 2013	Nov. 30, 2012
ASSETS
Cash and cash equivalents	$ 290,027	$ 199,472
Other current assets	11,807	11,293
Total current assets	301,834	210,765
Property and equipment, net of accumulated depreciation of $40,561	0	0
Other assets	280	280
Total assets	302,114	211,045
LIABILITIES AND EQUITY (DEFICIENCY)
Accounts payable and accrued expenses	1,047,652	1,106,177
Payable to related party	50,000	50,000
Advance from debenture holder	285,410	50,000
Convertible debentures	54,516	0
Current portion of deferred revenue	49,318	49,318
Total current liabilities	1,486,896	1,255,495
Non-current liabilities
Convertible debentures	0	56,026
Deferred revenue, net of current portion	486,412	498,741
Derivative liability related to Series B convertible preferred stock	67,145	19,245
Total non-current liabilities	553,557	574,012
Total liabilities	2,040,453	1,829,507
Commitments and contingencies	0	0
Equity (Deficiency) MultiCell Technologies, Inc. equity (deficiency)
Undesignated preferred stock	0	0
Common stock, $0.01 par value; 3,000,000,000 shares authorized; 1,534,358,585 and 1,349,803,029 shares issued and outstanding at February 28, 2013 and November 30, 2012, respectively	15,343,586	13,498,030
Additional paid-in capital	26,176,007	27,755,595
Accumulated deficit	(42,613,559)	(42,254,594)
Total MultiCell Technologies, Inc. stockholders' equity (deficiency)	(632,131)	(539,134)
Noncontrolling interests	(1,106,208)	(1,079,328)
Total equity (deficiency)	(1,738,339)	(1,618,462)
Total liabilities and equity (deficiency)	302,114	211,045
Series B Convertible Preferred Stock [Member]
Equity (Deficiency) MultiCell Technologies, Inc. equity (deficiency)
Undesignated preferred stock	461,835	461,835
Total equity (deficiency)	461,835	461,835
Series I Convertible Preferred Stock [Member]
Equity (Deficiency) MultiCell Technologies, Inc. equity (deficiency)
Undesignated preferred stock	0	0
Total equity (deficiency)	$ 0	$ 0